Get started
Author

Richard H. Greengold

A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer
2012 · C J Paller, X Ye, et al. · Prostate Cancer and Prostatic Diseases · 184
Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation
2020 · Benjamin A. Steinberg, DaJuanicia N. Holmes, et al. · Circulation Arrhythmia and Electrophysiology · 12
A phase II study of pomegranate extract for men with rising prostate-specific antigen following primary therapy.
2011 · M. A. Carducci, C. J. Paller, et al. · Journal of Clinical Oncology · 6
How to get the most benefit from a changing home health care system.
1997 · A Soundappan, T Goodwin, et al. · PubMed · 3
P10-1 open-label, multicenter study of sipuleucel-T in metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) previously treated with sipuleucel-T: Evaluation of antigen-presenting cell (APC) activation.
2013 · Tomasz M. Beer, L. Michael Glode, et al. · Journal of Clinical Oncology · 1
A phase II study of pomegranate extract for men with rising prostate-specific antigen following primary therapy.
2011 · C. J. Paller, X. Ye, et al. · Journal of Clinical Oncology · 1
Managed Care vs Universal Health Insurance: Whose Whips Are Gentler?
2000 · Richard H. Greengold · Archives of Internal Medicine · 1
Open-label, multicenter study of sipuleucel-T in men with metastatic castrate-resistant prostate cancer (mCRPC) previously treated with sipuleucel-T: Evaluation of antigen presenting cell (APC) activation and ELISPOT data.
2013 · Tomasz M. Beer, L. Michael Glode, et al. · Journal of Clinical Oncology
Works count: 8
Citation count: 208
H-index: 3
I10-index: 2
Year
Topic
Type